OPUS GENETICS INC. - COMMON STOCK
1.1800
01-十一月-24 14:59:56
15 分钟延时
股票
-0.0200
-1.67%
今日范围
1.1600 - 1.2185
ISIN
N/A
来源
NASDAQ
-
Ocuphire Pharma Announces Acquisition of Opus Genetics
22 10月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
30 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
05 9月 2024 19:43:59 条件 Nasdaq GlobeNewswire
-
05 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update
13 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Two Investor Conferences in August
08 8月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July
10 7月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
06 6月 2024 06:57:22 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
10 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
06 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the Aegis Virtual Conference
03 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
22 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
01 4月 2024 06:14:52 条件 Nasdaq GlobeNewswire
-
08 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present in the BIO CEO & Investor Conference
23 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 2月 2024 15:10:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
14 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
05 2月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 1月 2024 15:10:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >